Work

Use of advanced systemic therapy in patients with moderate-to-severe atopic dermatitis in the TARGET-DERM AD Registry

Year: 2024

Type: article

Study design: Observational Study

Source: Current Medical Research and Opinion

DOI: 10.1080/03007995.2024.2427883

Authors: Michael A. Haft, Keith D. Knapp, Ami Claxton, Breda Munoz, Julie M. Crawford, Sanjeev Balu, Yestle Kim, Shannon Schneider, Dawn Z. Eichenfield, Jonathan I. Silverberg, Lawrence F. Eichenfield, Jerry Bagel, Jamie L. W. Rhoads, Amy S. Paller

Institutions: University of California San Diego, Target PharmaSolutions, Inc. (United States), Leo Pharma (United States), George Washington University, Windsor Dermatology, University of Utah, Northwestern University

Language: English

Topic: Dermatology and Skin Diseases

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Target Real-world evidence

OpenAlex ID: W4404979444

FWCI: 1.027

Cites: 26

Cited by: 3

Related to: 10